Application of reagents for detecting gene expression levels and construction method of nac curative effect prediction model for breast cancer patients

A technology of gene expression level and detection method, applied in breast cancer-related fields, can solve problems such as the promotion and application of neoadjuvant chemotherapy affecting the benefit of patients, and achieve the effect of improving the breast conservation rate and predicting the curative effect.

Active Publication Date: 2022-05-06
WEST CHINA HOSPITAL SICHUAN UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the indications, specific chemotherapy regimens, chemotherapy schedules, and efficacy evaluation of neoadjuvant chemotherapy have not yet been completed, which affects the benefits of patients and the promotion and application of neoadjuvant chemotherapy to a certain extent.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of reagents for detecting gene expression levels and construction method of nac curative effect prediction model for breast cancer patients
  • Application of reagents for detecting gene expression levels and construction method of nac curative effect prediction model for breast cancer patients
  • Application of reagents for detecting gene expression levels and construction method of nac curative effect prediction model for breast cancer patients

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0080] The present embodiment provides a method for constructing a NAC curative effect prediction model for breast cancer patients, which includes the following steps:

[0081] Patient and Model

[0082]This study was approved by the Institutional Ethics Committee of West China Hospital (IRS number: 2017-476), and the clinical trial has been registered in the China Clinical Trial Registry (http: / / www.chictr.org.cn / ; Registration number: ChiCTR1800016763). The inventors retrospectively collected clinicopathological data of patients who underwent curative surgery and NAC treatment from January 2013 to December 2017. It should be noted that NAC treatment refers to a treatment plan of 4 or 6 cycles of anthracyclines combined with taxanes.

[0083] The NAC regimen includes a TEC regimen (every three weeks: docetaxel 75mg / m 2 , Epirubicin 50mg / m 2 and cyclophosphamide 500 mg / m 2 ) and PE regimen (weekly: paclitaxel 120mg / m 2 And epirubicin 50mg / m 2 , every 3 weeks as a course ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to view more

Abstract

The invention discloses the application of reagents for detecting gene expression levels and a method for constructing a NAC curative effect prediction model for breast cancer patients, and relates to the related technical field of breast cancer. The curative effect of chemotherapy, in order to provide the basis for breast cancer patients whether to accept neoadjuvant chemotherapy or what type of neoadjuvant chemotherapy to choose. Patients who are sensitive to chemotherapy regimens and may achieve pCR can seize the opportunity of neoadjuvant chemotherapy by predicting the curative effect, so as to perform effective neoadjuvant chemotherapy and improve breast-conserving rate or survival rate; while patients who are not sensitive to chemotherapy regimens may cause Patients with tumor progression, so that they can choose other effective treatments in time.

Description

technical field [0001] The invention relates to the technical field related to breast cancer, in particular to the application of reagents for detecting gene expression levels and the construction method of NAC curative effect prediction model for breast cancer patients. Background technique [0002] With the continuous improvement of diagnosis and treatment concepts and the rapid development of science and technology, the treatment effect of breast cancer has been significantly improved, but it is one of the most common malignant tumors in women. Today, the treatment of breast cancer is centered on radical surgery, combined with radiotherapy, chemotherapy and targeted therapy. Neoadjuvant chemotherapy (NAC) has been widely used in clinical practice. [0003] In addition to targeting patients with locally advanced breast cancer, NAC can also detect the sensitivity of chemotherapy regimens and strive for breast-conservation opportunities for downstaging, etc. Related studie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6886
CPCC12Q1/6886C12Q2600/106C12Q2600/158C12Q2600/166
Inventor 叶丰步宏郑鸿付波杨李波邓玲
Owner WEST CHINA HOSPITAL SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap